Searchable abstracts of presentations at key conferences in endocrinology

ea0009p94 | Endocrine tumours and neoplasia | BES2005

Development of a tamoxifen resistant breast cancer cell line

McVittie C , Khalaf S , Bustin S , Carpenter R , Jenkins P

Background: Tamoxifen is a partial estrogen agonist used to treat estrogen receptor positive breast cancer. It has been discovered however that resistance to tamoxifen develops in some cancers. In order to investigate the mechanisms underlying the development of resistance we have created a tamoxifen resistant breast cancer cell line.Aims: To develop a breast cancer cell line that is resistant to the anti-growth effects of tamoxifen.<p class="abstext...

ea0004oc16 | Endocrine tumours and neoplasia | SFE2002

IGF-I prevents deoxycholic acid-induced apoptosis in HT29 colorectal cells

Khalaf S , Ogunkolade W , Davies D , Bustin S , Jenkins P

Background: The pro-proliferative and anti-apoptotic IGF-I is implicated in the development of colorectal cancer (CRC) in both the general population and patients with acromegaly. The local intracolonic environment is also likely to be important, particularly unconjugated bile acids such as deoxycholic acid (DCA). Whilst low faecal concentrations may be proliferative, high levels are toxic to colonic epithelial cells.High levels of DCA have been linked t...

ea0002p22 | Cytokines and growth factors | SFE2001

The influence of IGFBP-3 on colonic epithelial cell proliferation and apoptosis

David T , Khalaf S , Davies D , Bustin S , Jenkins P

Background. Recent studies have linked high serum levels of IGF-1 and low levels of IGFBP-3 with an increased risk of colorectal cancer. BP3 has been shown to have IGF-1 independent effects on cell proliferation in breast and prostate cells, but its effects on colon cancer cells is largely unknown. Aims. To determine: 1) the effects of BP-3 on colonic epithelial cell proliferation and apoptosis, and 2) whether any effects are independent of IGF-1. Methods....

ea0073pep2.8 | Presented ePosters 2: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of serum uric acid concentration with diabetic retinopathy and its severity

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Ben Mami Faika

Background and aimDiabetes is the leading cause of adult blindness due to retinopathy. Serum uric acid levels independently predict the development of micro vascular complications. In this study, we analyze the relationship between serum uric acid (SUA) levels with the development and the severity of diabetic retinopathy(DR) in patients with type 2 diabetes mellitus (T2DM).Patients and MethodsA total of 100 T...

ea0073aep46 | Adrenal and Cardiovascular Endocrinology | ECE2021

High-normal serum uric acid levels in Type 2 diabetes patients with atherosclerotic cardiovascular diseases

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

Background and aimHyperuricemia is linked to a variety of diseases such as atherosclerotic cardiovascular disease (ASCVD). There are controversial data concerning the significance of high-normal values of serum uric acid (SUA) in patients with T2DM and cardiovascular disease. The aim of the study is to assess SUA levels in Type 2 diabetes mellitus (T2DM) patients with ASCVD.Patients and methodsThis retrospect...

ea0073aep283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Diabetic nephropathy in absence of diabetic retinopathy in type 2 diabetes mellitus patients

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

BackgroundThere is a well-recognized association between diabetic retinopathy (DN) and diabetic nephropathy (DN), in which nephropathy without retinopathy is rare but retinopathy without nephropathy is common.AimTo highlight the discordance between retinopathy and nephropathy and describe a series of patients with diabetic nephropathy who had no evidence of diabetic retinopathy.Methods<...

ea0073aep321 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Immune thrombocytopenia presenting with celiac disease and Hashimoto’s Thyroiditis in type 2 diabetes patient: A case report

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

IntroductionThe combination of at least three autoimmune diseases in the same patient is defined as multiple autoimmune syndrome. Recent studies demonstrated a higher prevalence of celiac disease in patients with immune thrombocytopenia when compared to the general population. Here we report the occurrence of celiac disease, Hashimoto’s disease and immune thrombocytopenia in type 2 diabetes patient.Case report<p class="abs...

ea0073aep714 | Thyroid | ECE2021

Thyroid disease in insulin- treated type 2 diabetes mellitus

Khalaf Rahma , Hadj Ali Zohra , Htira Yosra , Ben Mami Faika

Background and aimAbundant evidence suggests an association between thyroid disease and type 2 diabetes mellitus (T2DM). To determine the interaction between these co-existing pathologies, we analyzed insulin-treated type 2 diabetes patients with diagnosed thyroid disease.Patients and methodsThis retrospective study was performed in 54 type 2 diabetes patients who had been admitted for insulin-treatment and d...

ea0073ep65 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Glycemic control and microvascular complications in patients with type 1 diabetes and treated celiac disease

Khalaf Rahma , Hadj Ali Zohra , Htira Yosra , Ben Mami Faika

BackgroundCeliac disease (CD) occurs in patients with type1 diabetes (T1DM) ranging the prevalence of 4.4–11.1% versus 0.5% of the general population. The mechanism of association of these two diseases involves a shared genetic background.AimTo investigate whether in type1 diabetes (T1DM) patients the concomitance of treated celiac disease (CD) impacts glycemic control and the prevalence of microvascular...

ea0081p72 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Clinical and nutritional risk factors for insulin requirement during gestational diabetes mellitus

Khalaf Rahma , Htira Yosra , Hadj Ali Zohra , Jemai Chaima , Hedfi Imen , Mami Faika Ben

Background and aim: Gestational Diabetes Mellitus (GDM) is the commonest medical pregnancy complication. Nutritional interventions come to the fore as one of the few levers for managing GDM, as many medications are either harmful to the growing fetus, or their toxicity is uncertain. The aim of this study was to assess the potential clinical features and nutritional risk factors of insulin treatment during GDM.Methods: This was a prospective study includ...